Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,757 | -11,629 | -4,499 | -13,140 | -9,677 |
| Depreciation Amortization | N/A | 35 | 46 | 66 | 42 |
| Accounts receivable | -60 | -36 | -15 | 49 | -10 |
| Other Working Capital | -1,258 | -660 | -1,918 | 2,330 | 93 |
| Other Operating Activity | 1,825 | 2,072 | -10,969 | -4,606 | -3,789 |
| Operating Cash Flow | $-12,250 | $-10,218 | $-17,355 | $-15,301 | $-13,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -10 | -174 |
| Other Investing Activity | 201 | -201 | 0 | 0 | 0 |
| Investing Cash Flow | $201 | $-201 | $N/A | $-10 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 26,040 | 8,000 | N/A | N/A |
| Debt Repayment | -2,809 | -1,991 | N/A | N/A | N/A |
| Common Stock Issued | 36,000 | N/A | 3 | 38 | 252 |
| Other Financing Activity | 17,373 | -2,738 | 4,324 | 22,706 | 12,339 |
| Financing Cash Flow | $50,564 | $21,311 | $12,327 | $22,744 | $12,592 |
| Exchange Rate Effect | -22 | -19 | 0 | -27 | -1,198 |
| Beginning Cash Position | 14,829 | 3,957 | 8,985 | 1,579 | 3,700 |
| End Cash Position | 53,323 | 14,829 | 3,957 | 8,985 | 1,579 |
| Net Cash Flow | $38,494 | $10,872 | $-5,028 | $7,406 | $-2,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,250 | -10,218 | -17,355 | -15,301 | -13,340 |
| Capital Expenditure | N/A | N/A | N/A | -10 | -174 |
| Free Cash Flow | -12,250 | -10,218 | -17,355 | -15,311 | -13,514 |